Abstract
RNA interference (RNAi) has emerged as a promising tool for cancer treatment. A strenuous ongoing effort for translation of RNAi into clinically acceptable therapy is the development of vectors for efficient and targeted RNAi delivery. In this chapter, we review RNAi-based cancer treatment and the utility of dendrimers in RNAi delivery.
| Original language | English (US) |
|---|---|
| Title of host publication | Tailored Polymer Architectures for Pharmaceutical and Biomedical Applications |
| Publisher | American Chemical Society |
| Pages | 197-213 |
| Number of pages | 17 |
| ISBN (Print) | 9780841227989 |
| DOIs | |
| State | Published - Jul 8 2013 |
| Externally published | Yes |
Publication series
| Name | ACS Symposium Series |
|---|---|
| Volume | 1135 |
| ISSN (Print) | 0097-6156 |
| ISSN (Electronic) | 1947-5918 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- General Chemistry
- General Chemical Engineering
Fingerprint
Dive into the research topics of 'Dendrimer-based RNA interference delivery for cancer therapy'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS